Thus, SENP2 overexpression sensitizes MM cells to bortezomib, while depletion of SENP2 results in opposite effect, correlating with increased sumoylation of IκBa and thereby in activation of NF-κB [72]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.